HDL genetic defects

Area of Science:

• Biochemistry
• Genetics
• Cardiovascular Science

Background:

• High-density lipoprotein cholesterol (HDL-C) and apolipoproteins are crucial for reverse cholesterol transport.
• Genetic defects in HDL-C metabolism can alter plasma concentrations and HDL functionality.
• The clinical significance of HDL-C levels versus function in atherosclerosis is under investigation.

Purpose of the Study:

• To explore the impact of genetic defects on HDL-C metabolism and its relationship with cardiovascular disease.
• To investigate the role of specific mutations, such as the ApoA1 Milano mutation, in modulating atherosclerosis risk.
• To understand the pathophysiology of HDL-C disorders and inform potential therapeutic strategies.

Main Methods:

• Analysis of genetic mutations affecting HDL-C transport proteins and enzymes.
• Examination of familial hypoalphalipoproteinaemia, Tangier disease, and Fish Eye disease.
• Correlation of genetic defects with plasma HDL-C levels, HDL function, and atherosclerosis risk.

Main Results:

• Genetic defects influencing HDL-C biogenesis do not consistently correlate with atherosclerosis risk.
• The ApoA1 Milano mutation is associated with reduced atherosclerosis risk despite low HDL-C levels.
• Mutations in ABCA1 (Tangier disease) and LCAT (Fish Eye disease) result in very low HDL-C, with variable CVD associations.

Conclusions:

• HDL-C function may be more critical than concentration in cardiovascular health.
• Understanding HDL biogenesis mechanisms is vital for managing HDL-C related disorders.
• Further research into HDL-C metabolism could lead to novel treatments for dyslipidemia.